National Cancer Institute to Grant Exclusive Patent License to Nano Red LLC for Cancer Treatment

Summary

The National Cancer Institute is considering granting an exclusive patent license to Nano Red LLC to develop and use a photoactivatable liposomal nanoparticle for delivering immunotherapeutic agents, a potential breakthrough in cancer treatment.